Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Blueprint Medicines Conference Call. At this time, all participants are in listen-only-mode.
Source: insidermonkey.com
Stay updated with breaking news from Dane Leone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, and welcome to the Blueprint Medicines Conference Call. At this time, all participants are in listen-only-mode.
SGEN earnings call for the period ending December 31, 2022.
Seagen (SGEN – Research Report) received a Buy rating and a $175.00 price target from Raymond James analyst Dane Leone yesterday. The comp...
Operator: Greetings, and welcome to the Simulations Plus First Quarter Fiscal 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.